Atlas Trials

Mingfeng Zhao

1 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Mingfeng Zhao

RecordFirmDate
Clinical Study on the Safety, Efficacy and Pharmacokinetics of Universal CLL1 Chimeric Antigen Receptor T-Cell in Relapsed/Refractory Acute Myeloid Leukemia (NCT07432100)Mingfeng Zhao2026-02-01

Track Mingfeng Zhao automatically

Every clearance here is in the API, with alerts when new ones post.